IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Rhenman & Partners Asset Management AB

Q4 2016 Holdings

Filed 2017-01-13 | 108 holdings | $32.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Bristol Myers Squibb Co(BMY)COM110122108$16.4K281,0000.1%
Gilead Sciences Inc(GILD)COM375558103$18.6K259,8940.1%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$2.0M70,0006.3%
Coherus BioSciences Inc(CHRS)COM19249H103$3.1M111,3579.7%
BioMarin Pharmaceutical Inc(BMRN)COM09061G101$4.1M50,00012.8%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$5.1M135,00015.7%
AbbVie Inc(ABBV)COM00287Y109$7.2M115,00022.3%
Biogen Inc(BIIB)COM09062X103$10.2M36,00031.7%
PreviousPage 3 of 3